Consider a drug that is used to help prevent blood clots in certain patients. In clinicaltrials, among 6225

6225 patients treated with thisdrug, 150

150 developed the adverse reaction of nausea. Use a 0.05

0.05 significance level to test the claim that 3

3% of users develop nausea. Does nausea appear to be a problematic adversereaction?

Identify the null and alternative hypotheses for this test. Choose the correct answer below.

A.

Upper H 0

H0: pnot equals

0.03

0.03

Upper H 1

H1: pequals

=0.03

0.03

B.

Upper H 0

H0: pequals

=0.03

0.03

Upper H 1

H1: pgreater than

>0.03

0.03

C.

Upper H 0

H0: pequals

=0.03

0.03

Upper H 1

H1: pnot equals

0.03

0.03

D.

Upper H 0

H0: pequals

=0.03

0.03

Upper H 1

H1: pless than

<0.03

0.03

Identify the test statistic for this hypothesis test.

The test statistic for this hypothesis test is

nothing

.

(Round to two decimal places asneeded.)

Identify theP-value for this hypothesis test.

TheP-value for this hypothesis test is

nothing

.

(Round to three decimal places asneeded.)

Identify the conclusion for this hypothesis test.

A.

Reject

Reject Upper H 0

H0. There is not

isnot sufficient evidence to warrant rejection of the claim that 3

3% of users develop nausea.

B.

Reject

Reject Upper H 0

H0. There is

is sufficient evidence to warrant rejection of the claim that 3

3% of users develop nausea.

C.

Fail to reject

Failtoreject Upper H 0

H0. There is

is sufficient evidence to warrant rejection of the claim that 3

3% of users develop nausea.

D.

Fail to reject

Failtoreject Upper H 0

H0. There is not

isnot sufficient evidence to warrant rejection of the claim that 3

3% of users develop nausea.

Does nausea appear to be a problematic adversereaction?

Since the rate of nausea appears to be relatively

high,

low,

it

is not

is

a problematic adverse reaction.